Loading...
XLON
ANCR
Market cap308mUSD
Jul 09, Last price  
333.50GBP
1D
0.00%
1Q
36.12%
Jan 2017
11.17%
IPO
480.00%
Name

Animalcare Group PLC

Chart & Performance

D1W1MN
XLON:ANCR chart
P/E
45.35
P/S
2.58
EPS
0.07
Div Yield, %
1.56%
Shrs. gr., 5y
2.94%
Rev. gr., 5y
4.80%
Revenues
89m
+20.04%
8,301,00011,755,00017,638,00011,223,00011,825,00010,856,00012,118,00012,881,00013,536,00014,701,00015,867,00062,291,00072,470,00071,124,00070,494,00074,024,00071,616,00074,351,00074,228,00089,107,000
Net income
5m
-84.24%
250,000893,0001,039,000-1,031,0002,325,0001,729,0001,885,0002,137,0002,534,0002,634,0002,470,000184,000-222,000-1,338,000234,000-77,0001,965,0001,199,00032,217,0005,078,000
CFO
11m
-8.52%
984,0001,435,0002,433,0001,936,0002,145,0002,123,0002,831,0001,067,0003,892,0004,136,0002,421,0001,897,0007,430,00013,106,00011,117,00014,023,0009,429,00010,281,00011,933,00010,916,000
Dividend
Oct 16, 20252.2 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Animalcare Group plc specializes in the research, commercialization, and supply of licensed veterinary medicines and animal identification solutions. These products and services are developed for pets, livestock, and horses, serving their respective veterinary markets. The company also engages in the wholesale distribution and promotion of these specialized animal pharmaceuticals. With a broad international footprint, Animalcare Group plc caters to customers across Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, and Africa. Established in 1972, its operations are headquartered in York, United Kingdom.
IPO date
Jan 15, 2008
Employees
220
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT